Pfizer Inc. (NYSE:PFE) Receives $31.07 Consensus Target Price from Brokerages
Pfizer Inc. (NYSE:PFE – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the seventeen brokerages that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating, five have given a buy rating and three have assigned a […]
Pfizer Inc. (NYSE:PFE – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the seventeen brokerages that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating, five have given a buy rating and three have assigned a […]